Gå til resume Gå til indhold

Danish wholesale distributors of medicine have infringed competition rules

26. november 2014

The Danish Competition Council has required the two largest distributors on the Danish market, Nomeco A/S and Tjellesen Max Jenne A/S, to put an end to their coordination of fees and other trading conditions.

Director of the Danish Competition and Consumer Authority, Agnete Gersing, said:

"The two largest wholesale distributors of medicine have entered into an agreement regarding conditions and fees for the service they offer pharmacies and medicine manufacturers. This market is highly regulated. The agreement between the two distributors has impaired the few remaining competition parameters between them. This may have led to higher prices for the end consumer.”

The Danish Competition Council has required Nomeco A/S and Tjellesen Max Jenne A/S to put an end to their coordination of fees and other trading conditions, if they have not already done so.

Nomeco A/S and Tjellesen Max Jenne A/S are the largest wholesale distributors of medicine on the Danish marked. In 2013, they had a turnover of nearly DKK 9 billion (approximately EUR 1.2 billion).

The two distributors have restricted competition by agreeing a joint set of rules to all medicine manufacturers on the Danish market. The rules entered into force in January 2002 and concern, among other things, the prices for the handling of returned goods from the pharmacies. The Danish Competition and Consumer Authority obtained knowledge of the anti-competitive agreement after having conducted inspections at the business premises of the parties in January 2012.

Read the decision (only available in Danish)

For further information, please contact Communications Manager Hanne Arentoft, T: +45 4171 5098.

Last updated: 26. november 2014